Balak Salesh 4
4 · UNIVERSAL BIOSENSORS INC · Filed Feb 28, 2024
Insider Transaction Report
Form 4
Balak Salesh
Chief Financial Officier
Transactions
- Other
Stock Option (Right to Buy)
2024-02-27−216,300→ 0 totalExercise: $0.50Exp: 2024-02-27→ Common Stock (216,300 underlying)
Holdings
- 250,000
Performance Rights
Exp: 2025-03-24→ Common Stock (250,000 underlying) - 388,558
Common Stock
- 500,000
Performance Rights
Exp: 2025-03-24→ Common Stock (500,000 underlying) - 500,000
Stock Option (Right to Buy)
Exercise: $0.30Exp: 2025-03-24→ Common Stock (500,000 underlying)
Footnotes (5)
- [F1]The price reported is stated in Australian dollars.
- [F2]The options are fully vested and became exercisable on 03/01/2021.
- [F3]216,300 stock options vested and became exercisable on 12/31/2017. These options expired on 02/27/2024
- [F4]Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
- [F5]Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.